ÂÜÀòÂÒÂ×

Stephane Chatonsky is a seasoned professional with extensive experience in leadership and advisory roles across various sectors, including medical technology and investment. Currently serving as a Non Executive Director at Neo-Bionica, Cerulea Clinical Trials, Drop Bio Health, and as Board Chair at Brainmates, Stephane leverages expertise in product management and clinical trial oversight. Other roles include Chair of Syndicate groups at The CEO Institute, Co-Founder and Managing Director of IVEST, Expert Witness for the Federal Court of Australia, and Adjunct Faculty at The University of Queensland. Stephane holds an M.B.A. from The Wharton School and multiple executive education credentials from prestigious institutions such as INSEAD and Harvard Business School.